Wordt geladen...
Genomic Biomarkers of a Randomized Trial Comparing First-line Everolimus and Sunitinib in Patients with Metastatic Renal Cell Carcinoma
BACKGROUND: Metastatic renal cell carcinoma (RCC) patients are commonly treated with vascular endothelial growth factor (VEGF) inhibitors or mammalian target of rapamycin inhibitors. Correlations between somatic mutations and first-line targeted therapy outcomes have not been reported on a randomize...
Bewaard in:
| Gepubliceerd in: | Eur Urol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5431298/ https://ncbi.nlm.nih.gov/pubmed/27751729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2016.10.007 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|